Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Sci Rep ; 7: 44457, 2017 03 15.
Artículo en Inglés | MEDLINE | ID: mdl-28294151

RESUMEN

The gel to carbonate precipitate route has been used for the synthesis of Ni1-xZnxFe2O4 (x = 0, 0.25, 0.5 and 0.75) bulk inverse spinel ferrite powder samples. The optimal zinc (50%) substitution has shown the maximum saturation magnetic moment and resulted into the maximum magnetic loss tangent (tanδm) > -1.2 over the entire 2-10 GHz frequency range with an optimum value ~-1.75 at 6 GHz. Ni0.5Zn0.5Fe2O4- Acrylo-Nitrile Butadiene Rubber (NBR) composite samples are prepared at different weight percentage (wt%) of ferrite loading fractions in rubber for microwave absorption evaluation. The 80 wt% loaded Ni0.5Zn0.5Fe2O4/NBR composite (FMAR80) sample has shown two reflection loss (RL) peaks at 5 and 10 GHz. Interestingly, a single peak at 10 GHz for 3.25 mm thickness, can be scaled down to 5 GHz by increasing the thickness up to 4.6 mm. The onset of such twin matching frequencies in FMAR80 composite sample is attributed to the spin resonance relaxation at ~5 GHz (fm1) and destructive interference at λm/4 matched thickness near ~10 GHz (fm2) in these composite systems. These studies suggest the potential of tuning the twin frequencies in Ni0.5Zn0.5Fe2O4/NBR composite samples for possible microwave absorption applications.

2.
J Nanosci Nanotechnol ; 15(9): 6559-67, 2015 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-26716212

RESUMEN

In this paper, we report a simple but novel aqueous solution based 'one-pot' method for preparation of (NiFe2O4)x-(SrFe12O19)1-x nanocomposites consist of hard ferrite-soft ferrite phases. A physical mixing method has also been employed to prepare nanocomposites having same compositions. The effects of synthetic methodologies on the microstructures of the nanocomposites as well as their magnetic and microwave absorption properties have been evaluated. Crystal structures and microstructures of these composites have been investigated by using X-ray diffraction, transmission electron microscope and scanning electron microscope. In the nanocomposites, prepared by both methods, presence of nanocrystalline NiFe2O4 and SrFe12O19 phases was detected. However, nanocomposites, prepared by one-pot method, possessed better homogeneous distribution of hard and soft ferrite phases than the nanocomposites, prepared by physical mixing method. Nanocomposites, prepared by one-pot method, demonstrated significant spring exchange coupling interaction between hard and soft ferrite phases and exhibited magnetically single phase behaviour. The spring exchange coupling interaction enhanced the magnetic properties (high saturation magnetization and coercivity) and microwave absorption properties of the nanocomposites, prepared by one-pot method, in comparison with the nanocomposites prepared by physical mixing method as well as pure NiFe2O4 and SrFe12O19 nanoparticles. Minimum reflection loss of the composite was ~ -17 dB (i.e., 98% absorption) at 8.2 GHz for an absorber thickness of 3.2 mm.

3.
PDA J Pharm Sci Technol ; 62(5): 318-33, 2008.
Artículo en Inglés | MEDLINE | ID: mdl-19055228

RESUMEN

Virus filters are membrane-based devices that remove large viruses (e.g., retroviruses) and/or small viruses (e.g., parvoviruses) from products by a size exclusion mechanism. In 2002, the Parenteral Drug Association (PDA) organized the PDA Virus Filter Task Force to develop a common nomenclature and a standardized test method for classifying and identifying viral-retentive filters. One goal of the task force was to develop a test method for small virus-retentive filters. Because small virus-retentive filters present unique technical challenges, the test method development process was guided by laboratory studies to determine critical variables such as choice of bacteriophage challenge, choice of model protein, filtration operating parameters, target log10 reduction value, and filtration endpoint definition. Based on filtration, DLS, electrospray differential mobility analysis, and polymerase chain reaction studies, a final rating based on retention of bacteriophage PP7 was chosen by the PDA Virus Filter Task Force. The detailed final consensus filter method was published in the 2008 update of PDA Technical Report 41. Virus Filtration.


Asunto(s)
Levivirus/aislamiento & purificación , Membranas Artificiales , Filtros Microporos , Esterilización/instrumentación , Comités Consultivos , ADN Viral/aislamiento & purificación , Diseño de Equipo , Estudios de Factibilidad , Levivirus/genética , Levivirus/metabolismo , Luz , Ensayo de Materiales , Filtros Microporos/normas , Tamaño de la Partícula , Desarrollo de Programa , Unión Proteica , Reproducibilidad de los Resultados , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Dispersión de Radiación , Albúmina Sérica Bovina/metabolismo , Esterilización/normas , Virión/aislamiento & purificación
4.
PDA J Pharm Sci Technol ; 62(5): 334-43, 2008.
Artículo en Inglés | MEDLINE | ID: mdl-19055229

RESUMEN

Virus filters are membrane-based devices that remove large viruses (e.g., retroviruses) and/or small viruses (e.g., parvoviruses) from products by a size exclusion mechanism. In 2002, the Parenteral Drug Association (PDA) organized the PDA Virus Filter Task Force to develop a common nomenclature and a standardized test method for classifying and identifying viral-retentive filters. A test method based on bacteriophage PP7 retention was chosen based on developmental studies. The detailed final consensus filter method is published in the 2008 update of PDA Technical Report 41: Virus Filtration. Here, we evaluate the method and find it to be acceptable for testing scaled-down models of small virus-retentive filters from four manufacturers. Three consecutive lots of five filter types were tested (Pegasus SV4, Viresolve NFP, Planova 20N and 15N, Virosart CPV). Each passed the criteria specified in the test method (i.e., >4 log10 PP7 retention, >90% intravenous immunoglobulin passage, and passing integrity/installation testing) and was classified as PP7-LRV4.


Asunto(s)
Levivirus/aislamiento & purificación , Membranas Artificiales , Filtros Microporos , Esterilización/instrumentación , Diseño de Equipo , Guías como Asunto , Inmunoglobulinas Intravenosas/análisis , Ensayo de Materiales , Filtros Microporos/normas , Evaluación de Programas y Proyectos de Salud , Reproducibilidad de los Resultados , Esterilización/normas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...